Evolent Health (EVH) Short Interest Ratio & Short Volume → Elon’s New Device is About to Shock the World (From InvestorPlace) (Ad) Free EVH Stock Alerts $24.46 -2.50 (-9.27%) (As of 05/10/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Evolent Health Short Interest DataCurrent Short Volume11,250,000 sharesPrevious Short Volume11,380,000 sharesChange Vs. Previous Month-1.14%Dollar Volume Sold Short$312.30 millionShort Interest Ratio / Days to Cover12.0Last Record DateApril 30, 2024Outstanding Shares115,430,000 sharesPercentage of Shares Shorted9.75%Today's Trading Volume5,291,035 sharesAverage Trading Volume882,880 sharesToday's Volume Vs. Average599% Short Selling Evolent Health ? Sign up to receive the latest short interest report for Evolent Health and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatEVH Short Interest Over TimeEVH Days to Cover Over TimeEVH Percentage of Float Shorted Over Time Ad Banyan Hill PublishingForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsIf you think AI is big, then you have got to check out something I call Imperium… By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.)Watch my video for all of the details Evolent Health Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202411,250,000 shares $312.30 million -1.1%N/A12 $27.76 4/15/202411,380,000 shares $344.70 million +7.3%N/A12.2 $30.29 3/31/202410,610,000 shares $347.90 million -1.9%N/A11 $32.79 3/15/202410,810,000 shares $353.16 million -3.8%N/A11 $32.67 2/29/202411,240,000 shares $381.15 million -0.7%N/A8.9 $33.91 2/15/202411,320,000 shares $353.58 million +1.2%N/A8.1 $31.24 Get the Latest News and Ratings for EVH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Evolent Health and its competitors with MarketBeat's FREE daily newsletter. 1/31/202411,190,000 shares $329.10 million +3.7%N/A8.6 $29.41 1/15/202410,790,000 shares $339.67 million +0.9%N/A7.8 $31.48 12/31/202310,690,000 shares $353.09 million -3.9%N/A7.7 $33.03 12/15/202311,120,000 shares $337.38 million +42.0%N/A8.3 $30.34 11/30/20237,830,000 shares $217.60 million -5.2%N/A6 $27.79 11/15/20238,260,000 shares $245.32 million +0.5%N/A8.5 $29.70 10/31/20238,220,000 shares $200.81 million -1.2%N/A8.4 $24.43 10/15/20238,320,000 shares $232.96 million +0.1%N/A9.5 $28.00 9/30/20238,310,000 shares $226.28 million +9.3%N/A9.2 $27.23 9/15/20237,600,000 shares $199.12 million +5.1%N/A7 $26.20 8/31/20237,230,000 shares $184.37 million -1.4%N/A6.2 $25.50 8/15/20237,330,000 shares $204.87 million -1.5%N/A6 $27.95 7/31/20237,440,000 shares $226.10 million -11.4%N/A6 $30.39 7/15/20238,400,000 shares $254.10 million -1.1%N/A6.6 $30.25 6/30/20238,490,000 shares $257.12 million +36.9%N/A6.8 $30.29 6/15/20236,200,000 shares $185.07 million -1.4%N/A5.4 $29.85 5/31/20236,290,000 shares $183.35 million +8.6%N/A6.8 $29.15 5/15/20235,790,000 shares $201.78 million +9.7%N/A5.9 $34.85 4/30/20235,280,000 shares $192.24 million +3.1%N/A5.7 $36.41 4/15/20235,120,000 shares $168.35 million -4.7%N/A5.9 $32.88 3/31/20235,370,000 shares $174.26 million +3.7%N/A5.7 $32.45 3/15/20235,180,000 shares $156.90 million -9.4%N/A5.3 $30.29 2/28/20235,720,000 shares $200.26 million -2.4%N/A6 $35.01 2/15/20235,860,000 shares $197.01 million -8.7%N/A6.2 $33.62 1/31/20236,420,000 shares $206.85 million -12.9%N/A6 $32.22 1/15/20237,370,000 shares $233.33 million -0.8%N/A6.5 $31.66 12/30/20227,430,000 shares $208.63 million +7.2%N/A6.6 $28.08 12/15/20226,930,000 shares $192.03 million -6.5%N/A6.2 $27.71 11/30/20227,410,000 shares $213.33 million +3.5%N/A6.4 $28.79 11/15/20227,160,000 shares $182.15 million +11.7%N/A5.9 $25.44 10/31/20226,410,000 shares $203.90 million -4.0%N/A5.4 $31.81 10/15/20226,680,000 shares $207.75 million -4.4%N/A5.9 $31.10 9/30/20226,990,000 shares $251.15 million +5.4%N/A6.4 $35.93 9/15/20226,630,000 shares $258.04 million +3.6%N/A5.8 $38.92Missed NVDA? Buy this AI stock NOW (Ad)After Nvidia's record-breaking earnings surge, Wall Street is now selling the stock at the fastest pace in seven months. So if you currently own NVIDIA (NVDA)... Or were thinking of buying it in the weeks ahead... I urge you to review my recent interview with 50-year Wall Street legend Marc Chaikin.You can watch it here. EVH Short Interest - Frequently Asked Questions What is Evolent Health's current short interest? Short interest is the volume of Evolent Health shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 11,250,000 shares of EVH short. Learn More on Evolent Health's current short interest. What is a good short interest ratio for Evolent Health? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. EVH shares currently have a short interest ratio of 12.0. Learn More on Evolent Health's short interest ratio. Which institutional investors are shorting Evolent Health? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Evolent Health: Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Evolent Health's short interest increasing or decreasing? Evolent Health saw a drop in short interest in the month of April. As of April 30th, there was short interest totaling 11,250,000 shares, a drop of 1.1% from the previous total of 11,380,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Evolent Health's short interest compare to its competitors? Here is how the short interest of companies in the sector of "computer and technology" compare to Evolent Health: Paycor HCM, Inc. (8.93%), Teradata Co. (3.33%), Vishay Intertechnology, Inc. (8.69%), Hayward Holdings, Inc. (8.89%), Wolfspeed, Inc. (19.52%), United States Cellular Co. (7.90%), C3.ai, Inc. (27.37%), Autohome Inc. (1.14%), Cogent Communications Holdings, Inc. (7.85%), Plexus Corp. (2.19%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Evolent Health stock? Short selling EVH is an investing strategy that aims to generate trading profit from Evolent Health as its price is falling. EVH shares are trading down $2.50 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Evolent Health? A short squeeze for Evolent Health occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of EVH, which in turn drives the price of the stock up even further. How often is Evolent Health's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EVH, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: PYCR Short Squeeze TDC Short Squeeze VSH Short Squeeze HAYW Short Squeeze WOLF Short Squeeze USM Short Squeeze AI Short Squeeze ATHM Short Squeeze CCOI Short Squeeze PLXS Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NYSE:EVH) was last updated on 5/12/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsYou need to know these two things about AI stocks ASAP…InvestorPlaceGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchMissed NVDA? Buy this AI stock NOWChaikin AnalyticsShocking: One AI startup's revenue could surge 4,735%Manward Press[Webinar] A Deep Dive into Options Volatility: Skew & Relative ValueOICCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill Publishing